Cigna Q1 Earnings Beat Expectations, Lifts FY22 Guidance

Cigna Corp CI reports Q1 total revenues of $44.12 billion, +7.6% Y/Y, ahead of the consensus of $43.41 billion.
Cigna brought in $1.18 billion in earnings, up from $1.16 billion a year ago.
Q1 adjusted EPS reached $6.01 compared with $4.73 a year ago, beating the consensus of $5.18.
By the end of 2021, Cigna boasted 107.4 million pharmacy benefit customers, a gain of 6.4 million over the year. Medical membership reached 17.78 million, up from 16.67 million a year ago.
At its Evernorth subsidiary, revenues were up 10% Y/Y reaching $33.58 billion, reflecting organic growth in specialty pharmacy services.
Revenues were up 3% at its health plan, reaching $11.39 billion.
Guidance: For FY22, Cigna expects EPS of at least $22.60 (consensus of $22.49), up from prior guidance of at least $22.40
It reaffirms FY22 revenues of at least $177 billion.
For FY22, the Company expects total Medical Customer Growth (lives) of at least 725,000, up from the 575,000 anticipated earlier.
Price Action: CI shares closed at $252.08 on Thursday.

Earnings Calendar